Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
Article has an altmetric score of 12

See more details

Referenced in 3 patents
Referenced in 1 Wikipedia pages
Referenced in 1 clinical guideline sources
30 readers on Mendeley
  • Article usage
  • Citations to this article (277)

Advertisement

Research Article Free access | 10.1172/JCI113949

Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.

M P Manns, E F Johnson, K J Griffin, E M Tan, and K F Sullivan

W. M. Keck Autoimmune Disease Center, La Jolla, California.

Find articles by Manns, M. in: PubMed | Google Scholar

W. M. Keck Autoimmune Disease Center, La Jolla, California.

Find articles by Johnson, E. in: PubMed | Google Scholar

W. M. Keck Autoimmune Disease Center, La Jolla, California.

Find articles by Griffin, K. in: PubMed | Google Scholar

W. M. Keck Autoimmune Disease Center, La Jolla, California.

Find articles by Tan, E. in: PubMed | Google Scholar

W. M. Keck Autoimmune Disease Center, La Jolla, California.

Find articles by Sullivan, K. in: PubMed | Google Scholar

Published March 1, 1989 - More info

Published in Volume 83, Issue 3 on March 1, 1989
J Clin Invest. 1989;83(3):1066–1072. https://doi.org/10.1172/JCI113949.
© 1989 The American Society for Clinical Investigation
Published March 1, 1989 - Version history
View PDF
Abstract

Type 1, liver kidney microsomal autoantibodies (LKM-1) are associated with a subgroup of idiopathic autoimmune type, chronic active hepatitis (CAH). The antigenic specificity of LKM-1 autoantibodies from 13 patients was investigated by immunoblot analysis of human liver microsomal proteins. Polypeptides of 50, 55, and 64 kD were detected with these antisera. A high titer LKM-1 serum was selected to screen a human liver lambda gt11 cDNA expression library, resulting in the isolation of several complementary (c)DNA clones. Autoantibodies affinity purified from proteins expressed by two of the immunopositive cDNA clones, HLD8.2 and HLD13.2, specifically react with a 50-kD protein of human liver microsomes and display immunofluorescence staining of the proximal renal tubular epithelia characteristic of LKM-1 sera. Determination of the sequence of HLD8.2 revealed that it encodes a recently described cytochrome P450db1. A bacterial fusion protein constructed from HLD8.2 proved to be a specific and sensitive diagnostic reagent. All sera from patients with LKM-1 positive liver disease react with this fusion protein. No reaction was seen, however, for sera from patients with other types of autoimmune liver diseases, viral hepatitis, systemic immunological disorders, or healthy controls.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1066
page 1066
icon of scanned page 1067
page 1067
icon of scanned page 1068
page 1068
icon of scanned page 1069
page 1069
icon of scanned page 1070
page 1070
icon of scanned page 1071
page 1071
icon of scanned page 1072
page 1072
Version history
  • Version 1 (March 1, 1989): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 12
  • Article usage
  • Citations to this article (277)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 3 patents
Referenced in 1 Wikipedia pages
Referenced in 1 clinical guideline sources
30 readers on Mendeley
See more details